To include your compound in the COVID-19 Resource Center, submit it here.

Techniques: Co-crystal structure of human cytomegalovirus (CMV) glycoprotein B and a broadly neutralizing antibody (bNAb) against CMV to aid vaccine design

Drug

Read the full 13 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE